Skip to content

Web-based Resource for Children and Adolescents About Clinical Research

Web-based Resource for Children and Adolescents About Clinical Research

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04448210
Enrollment
42
Registered
2020-06-25
Start date
2020-06-30
Completion date
2020-08-02
Last updated
2020-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Illnesses, Multiple, Healthy

Brief summary

The overall aims of this project are to: 1) create a developmentally appropriate interactive educational website for adolescents called DigiKnowIt News: Teen, and 2) examine the feasibility of DigiKnowIt News: Teen in a small randomized control trial with adolescents.

Detailed description

Youth (N=30) will be recruited to participate in the feasibility study. Parent permission and youth assent will be sought. Participants will be randomized into one of two study arms: intervention and wait-list control. All participants will complete a web-based pre-test questionnaire. Youth in the intervention group will then receive access to DigiKnowIt News: Teen for one week. Approximately one week after completing the pre-test questionnaire, all participants will complete a web-based post-test questionnaire (the post-test for youth in the intervention group will also include Consumer Satisfaction Questions). Youth in the wait-list control group will then receive access to DigiKnowIt News: Teen for one week. After one week, they will complete a Consumer Satisfaction Questionnaire.

Interventions

Teens will interact with a multimedia educational website that will teach them about pediatric clinical trials including topics such as participant rights and safety, benefits and costs to participating in a study, and different types of procedures used in trials.

Sponsors

Innovation Research & Training
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants must be between the ages of 12 and 17 years. * Participants must have access to a computer or tablet with Internet connection. * Participants must be able to read and write in English fluently.

Exclusion criteria

* Participants must NOT have previously participated in a clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Knowledge Scores at 1 Week1 weekYouth will respond to 25 questions that assess their factual knowledge about clinical research (e.g., Who is part of a clinical trial?). Questions are in multiple choice format and some questions have multiple correct answers. The correct responses were summed across the questions. The range of scores is from 0 to 46. Higher scores indicate more knowledge about clinical research.
Attitudes Scores at 1 Week1 weekYouth will be asked to respond to 6 questions that assess their positive attitudes about clinical trials (e.g., How do you feel about kids participating in clinical trials?; 1=Not good at all; 2=Not very good; 3=Not sure; 4=Good; 5=Very good). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more positive attitudes toward clinical trials.
Beliefs Scores at 1 Week1 weekYouth will be asked to respond to 5 questions that assess their beliefs about positive aspects of pediatric clinical research (e.g., I believe that clinical trials can help kids; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more positive beliefs about clinical research.
Self-Efficacy to Communicate Scores at 1 Week1 weekYouth will be asked to respond to 10 questions related to their self-efficacy for making decisions related to participation in clinical trials for communicating about clinical trials (e.g., Tell the researcher that I don't want to participate in the clinical trial, even if they really want me to do it; 1 = I cannot do it at all; 5 = I know I can do it.). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more self-efficacy about communicating about clinical trials.
Self-Efficacy to Gather Information Scores at 1 Week1 weekYouth will be asked to respond to 9 questions related to their self-efficacy for making decisions related to participation in clinical trials for gathering information about clinical trials (e.g., How sure are you that you can do the following things: Ask my parents questions for more information about clinical trials?; 1 = I cannot do it at all; 5 = I know I can do it.). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more self-efficacy for gathering information about clinical trials.
Confidence Scores at 1 Week1 weekYouth will be asked to respond to 3 questions to measure youths' confidence for participating clinical trials (e.g., I know what rights I have in a clinical trial. I know whom to ask if I need more information about a clinical trial.; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more confidence for participating in clinical trials.
Procedural Fears Scores at 1 Week1 weekYouth will be asked to respond to 4 questions related to their perceptions of fear or anxiety about different types of medical procedures, including getting a needle in the arm, injection in the leg, getting a scan, and taking new medicine, on a 5-point Likert scale (1 = Not at all afraid or anxious, 2 = Somewhat afraid or anxious, 3 = Moderately afraid or anxious, 4 = Very afraid or anxious, 5 = Extremely afraid or anxious). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more fears about medical procedures.
Likelihood of Participation Scores at 1 Week1 weekYouth will be asked to respond to one question about the likelihood of participating in a clinical trial (i.e., If you were asked to be in a clinical trial, how likely would you be to participate?) using a 5-point Likert scale (1 = Not likely; 5 = Extremely likely). The minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate increased likelihood of participating in a clinical trial.
Fear Preventing Participation Scores at 1 Week1 weekYouth will be asked to respond to one question about the likelihood of their fear preventing them from participating in a clinical trial (i.e., How likely is it that your fearful or anxious feelings could stop you from participating in a clinical trial in the future?) using a 5-point Likert scale (1 = Not likely; 5 = Extremely likely). The minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate increased likelihood of fear preventing them from participating in a clinical trial.

Countries

United States

Participant flow

Participants by arm

ArmCount
Educational Website Intervention
The intervention is an educational website designed to teach youth (12-17 years) about pediatric clinical trials. DigiKnowIt News: Teen: Teens will interact with a multimedia educational website that will teach them about pediatric clinical trials including topics such as participant rights and safety, benefits and costs to participating in a study, and different types of procedures used in trials.
22
Wait-list Control
The wait-list control group did not receive the intervention between the pre-test and post-test assessments. After completing the post-test questionnaire, youth in the wait-list control group had the option to receive access to the intervention (DigiKnowIt News).
20
Total42

Baseline characteristics

CharacteristicWait-list ControlTotalEducational Website Intervention
Age, Continuous14.55 years
STANDARD_DEVIATION 1.64
14.33 years
STANDARD_DEVIATION 1.71
14.14 years
STANDARD_DEVIATION 1.78
Baseline Attitudes Scores3.85 units on a scale
STANDARD_DEVIATION 0.65
3.80 units on a scale
STANDARD_DEVIATION 0.7
3.76 units on a scale
STANDARD_DEVIATION 0.75
Baseline Beliefs Scores4.21 units on a scale
STANDARD_DEVIATION 0.51
4.16 units on a scale
STANDARD_DEVIATION 0.58
4.11 units on a scale
STANDARD_DEVIATION 0.64
Baseline Confidence Scores3.35 units on a scale
STANDARD_DEVIATION 0.63
3.37 units on a scale
STANDARD_DEVIATION 0.64
3.39 units on a scale
STANDARD_DEVIATION 0.67
Baseline Fear Preventing Participation Scores2.35 units on a scale
STANDARD_DEVIATION 1.09
2.32 units on a scale
STANDARD_DEVIATION 0.93
2.29 units on a scale
STANDARD_DEVIATION 0.78
Baseline Knowledge Scores36.25 units on a scale
STANDARD_DEVIATION 4.04
36.00 units on a scale
STANDARD_DEVIATION 4.47
35.74 units on a scale
STANDARD_DEVIATION 4.96
Baseline Likelihood of Participation Scores3.74 units on a scale
STANDARD_DEVIATION 0.81
3.65 units on a scale
STANDARD_DEVIATION 0.89
3.57 units on a scale
STANDARD_DEVIATION 0.98
Baseline Procedural Fears Scores2.46 units on a scale
STANDARD_DEVIATION 0.8
2.37 units on a scale
STANDARD_DEVIATION 0.77
2.28 units on a scale
STANDARD_DEVIATION 0.75
Baseline Self-Efficacy for Gathering Information Scores4.21 units on a scale
STANDARD_DEVIATION 0.52
4.22 units on a scale
STANDARD_DEVIATION 0.56
4.23 units on a scale
STANDARD_DEVIATION 0.61
Baseline Self-Efficacy to Communicate Scores4.56 units on a scale
STANDARD_DEVIATION 0.54
4.52 units on a scale
STANDARD_DEVIATION 0.57
4.49 units on a scale
STANDARD_DEVIATION 0.61
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants8 Participants5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
17 Participants34 Participants17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
3 Participants3 Participants0 Participants
Race (NIH/OMB)
More than one race
5 Participants7 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
12 Participants30 Participants18 Participants
Sex/Gender, Customized
Female
10 Participants20 Participants10 Participants
Sex/Gender, Customized
Male
8 Participants20 Participants12 Participants
Sex/Gender, Customized
Non-Binary
2 Participants2 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 220 / 20
serious
Total, serious adverse events
0 / 220 / 20

Outcome results

Primary

Attitudes Scores at 1 Week

Youth will be asked to respond to 6 questions that assess their positive attitudes about clinical trials (e.g., How do you feel about kids participating in clinical trials?; 1=Not good at all; 2=Not very good; 3=Not sure; 4=Good; 5=Very good). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more positive attitudes toward clinical trials.

Time frame: 1 week

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionAttitudes Scores at 1 Week3.92 units on a scaleStandard Error 0.09
Wait-list ControlAttitudes Scores at 1 Week3.87 units on a scaleStandard Error 0.09
p-value: 0.72ANOVA
Primary

Beliefs Scores at 1 Week

Youth will be asked to respond to 5 questions that assess their beliefs about positive aspects of pediatric clinical research (e.g., I believe that clinical trials can help kids; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more positive beliefs about clinical research.

Time frame: 1 week

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionBeliefs Scores at 1 Week4.40 units on a scaleStandard Error 0.09
Wait-list ControlBeliefs Scores at 1 Week4.23 units on a scaleStandard Error 0.09
p-value: 0.16ANOVA
Primary

Confidence Scores at 1 Week

Youth will be asked to respond to 3 questions to measure youths' confidence for participating clinical trials (e.g., I know what rights I have in a clinical trial. I know whom to ask if I need more information about a clinical trial.; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more confidence for participating in clinical trials.

Time frame: 1 week

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionConfidence Scores at 1 Week3.91 units on a scaleStandard Error 0.14
Wait-list ControlConfidence Scores at 1 Week3.73 units on a scaleStandard Error 0.14
p-value: 0.38ANOVA
Primary

Fear Preventing Participation Scores at 1 Week

Youth will be asked to respond to one question about the likelihood of their fear preventing them from participating in a clinical trial (i.e., How likely is it that your fearful or anxious feelings could stop you from participating in a clinical trial in the future?) using a 5-point Likert scale (1 = Not likely; 5 = Extremely likely). The minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate increased likelihood of fear preventing them from participating in a clinical trial.

Time frame: 1 week

Population: In this study, participants were able to skip questions in the questionnaires. Thus, there may not be complete data for all participants for this outcome.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionFear Preventing Participation Scores at 1 Week2.13 units on a scaleStandard Error 0.18
Wait-list ControlFear Preventing Participation Scores at 1 Week2.40 units on a scaleStandard Error 0.18
p-value: 0.3ANOVA
Primary

Knowledge Scores at 1 Week

Youth will respond to 25 questions that assess their factual knowledge about clinical research (e.g., Who is part of a clinical trial?). Questions are in multiple choice format and some questions have multiple correct answers. The correct responses were summed across the questions. The range of scores is from 0 to 46. Higher scores indicate more knowledge about clinical research.

Time frame: 1 week

Population: In this study, participants were able to skip questions in the questionnaires. Thus, there may not be complete data for all participants for this outcome.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionKnowledge Scores at 1 Week35.32 units on a scaleStandard Error 1
Wait-list ControlKnowledge Scores at 1 Week36.93 units on a scaleStandard Error 0.94
p-value: <0.25ANOVA
Primary

Likelihood of Participation Scores at 1 Week

Youth will be asked to respond to one question about the likelihood of participating in a clinical trial (i.e., If you were asked to be in a clinical trial, how likely would you be to participate?) using a 5-point Likert scale (1 = Not likely; 5 = Extremely likely). The minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate increased likelihood of participating in a clinical trial.

Time frame: 1 week

Population: In this study, participants were able to skip questions in the questionnaires. Thus, there may not be complete data for all participants for this outcome.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionLikelihood of Participation Scores at 1 Week3.63 units on a scaleStandard Error 0.15
Wait-list ControlLikelihood of Participation Scores at 1 Week3.65 units on a scaleStandard Error 0.15
p-value: 0.94ANOVA
Primary

Procedural Fears Scores at 1 Week

Youth will be asked to respond to 4 questions related to their perceptions of fear or anxiety about different types of medical procedures, including getting a needle in the arm, injection in the leg, getting a scan, and taking new medicine, on a 5-point Likert scale (1 = Not at all afraid or anxious, 2 = Somewhat afraid or anxious, 3 = Moderately afraid or anxious, 4 = Very afraid or anxious, 5 = Extremely afraid or anxious). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more fears about medical procedures.

Time frame: 1 week

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionProcedural Fears Scores at 1 Week2.25 units on a scaleStandard Error 0.1
Wait-list ControlProcedural Fears Scores at 1 Week2.24 units on a scaleStandard Error 0.1
p-value: 0.94ANOVA
Primary

Self-Efficacy to Communicate Scores at 1 Week

Youth will be asked to respond to 10 questions related to their self-efficacy for making decisions related to participation in clinical trials for communicating about clinical trials (e.g., Tell the researcher that I don't want to participate in the clinical trial, even if they really want me to do it; 1 = I cannot do it at all; 5 = I know I can do it.). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more self-efficacy about communicating about clinical trials.

Time frame: 1 week

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionSelf-Efficacy to Communicate Scores at 1 Week4.59 units on a scaleStandard Error 0.1
Wait-list ControlSelf-Efficacy to Communicate Scores at 1 Week4.48 units on a scaleStandard Error 0.1
p-value: 0.43ANOVA
Primary

Self-Efficacy to Gather Information Scores at 1 Week

Youth will be asked to respond to 9 questions related to their self-efficacy for making decisions related to participation in clinical trials for gathering information about clinical trials (e.g., How sure are you that you can do the following things: Ask my parents questions for more information about clinical trials?; 1 = I cannot do it at all; 5 = I know I can do it.). Responses to this scale were averaged and the minimum scale score was 1 and the maximum scale score was 5. Higher scores indicate more self-efficacy for gathering information about clinical trials.

Time frame: 1 week

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Educational Website InterventionSelf-Efficacy to Gather Information Scores at 1 Week4.33 units on a scaleStandard Error 0.09
Wait-list ControlSelf-Efficacy to Gather Information Scores at 1 Week4.38 units on a scaleStandard Error 0.09
p-value: 0.69ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026